The future of biological research may be getting a significant upgrade thanks to a new innovation in lab-on-a-chip technology. Researchers at ETH Zurich have developed a microchip featuring tiny, low-power grippers capable of manipulating cells and organoids – miniature, 3D models of organs – with unprecedented precision. This advancement, presented at the IEEE International Solid State Circuits Conference in San Francisco on February 18, 2026, promises to enhance our ability to study human biology and accelerate drug discovery. The development addresses a key challenge in the field: reliably handling and positioning these delicate biological structures within microfluidic devices.
These “organs-on-a-chip” are gaining prominence as alternatives to traditional 2D cell cultures and animal models, offering a more realistic environment to study human physiology and disease. Organoids, derived from stem cells, mimic the complex structure and function of human organs, providing a powerful tool for understanding development, disease mechanisms, and testing potential therapies. However, maintaining the precise arrangement and interaction of cells within these systems has been a significant hurdle. The new chip, integrating shape-memory grippers and chemical sensors, offers a potential solution, allowing for both precise manipulation and real-time monitoring of biological processes. This technology builds upon advancements in microfluidics, which allows for the precise control of fluids in micro-scale channels, and bioelectronics, which integrates electronic components with biological systems.
The core innovation lies in the use of shape-memory alloys – materials that change shape in response to electrical signals – to create micro-cages that can gently grasp and hold biological samples. Unlike existing methods like optical or acoustic tweezers, which can generate heat or require continuous power, these grippers maintain their position without ongoing energy input once activated. This low-power operation is crucial for long-term cell culture and minimizes potential damage to sensitive biological samples. The ability to manipulate organoids and cells within a controlled microenvironment opens up new possibilities for studying complex biological processes and developing personalized medicine approaches.
Precision Gripping at the Microscale
The ETH Zurich chip features an array of nine micro-cage sets, each equipped with control electrodes and chemical sensors. The cages themselves are nested, resembling concentric flower petals, and come in three sizes – 100, 150, and 280 micrometers – to accommodate a range of sample sizes, from single cells to entire organoids. These varying sizes allow researchers to handle diverse biological materials with optimal precision. The arms of the cages are constructed from layered platinum and titanium, materials chosen for their biocompatibility and responsiveness to electrical signals.
The operation of the grippers is elegantly simple. By applying a specific electrical signal to the control electrode, the platinum layer undergoes an electrochemical change, causing the titanium arms to bend and curl upwards, effectively “caging” the biological sample. Once the desired shape is achieved, the grippers remain locked in place without requiring further power. Reversing the signal causes the arms to flatten, releasing the sample. This on-demand control is a significant advantage over other manipulation techniques. The chip as well incorporates electrochemical sensors made of gold, platinum, and palladium, enhancing its ability to detect and measure biochemical signals within the microenvironment. According to Adam Wang, an electrical engineer at ETH Zurich, using different electrode materials with varying properties increases the sensitivity of the system. ETH Zurich researchers have demonstrated the chip’s ability to grip onto glass beads and measure concentrations of ferrocyanide, a chemical commonly used for sensor testing.
Applications in Organoid Research and Beyond
The potential applications of this technology are vast, particularly in the rapidly growing field of organoid research. Researchers are increasingly using organoids to model human diseases and test new drugs, but controlling their development and studying their function remains a challenge. For example, neural organoids – miniature brain models grown in the lab – are being used to study brain development and the effects of chemicals or drugs on neural tissue. Neural organoids offer a unique opportunity to investigate complex neurological disorders and develop targeted therapies. The new chip’s grippers could be used to hold these organoids in place, or to bring different tissue samples together to encourage their development and interaction.
Beyond neural organoids, the technology could be applied to a wide range of organ systems, including the intestine, kidney, lung, liver, pancreas, heart, and even tumors. Integrating organoids and organ-on-a-chip devices is a rapidly evolving field, aiming to bridge the gap between traditional 2D cell cultures and animal models. The ability to precisely control the microenvironment around organoids, combined with real-time sensing capabilities, could lead to more accurate and reliable disease models. The chip’s low-power operation makes it suitable for long-term studies and high-throughput screening of drug candidates. The researchers are now working to demonstrate the chip’s ability to handle biological cells and organoids, and to measure biochemicals such as neurotransmitters.
The Rise of Lab-on-a-Chip Technology
The development of this new chip is part of a broader trend towards miniaturizing and automating biological experiments using lab-on-a-chip technology. These devices integrate multiple laboratory functions onto a single chip, offering advantages such as reduced reagent consumption, faster analysis times, and increased throughput. Organoids-on-a-chip, in particular, are gaining traction as a powerful tool for personalized medicine. By growing organoids from a patient’s own cells, doctors could potentially test different drugs and treatments to determine the most effective course of action. This approach promises to revolutionize healthcare by tailoring treatments to individual patients, maximizing efficacy and minimizing side effects.
Building bioelectronic systems directly onto a chip offers several advantages, including the ability to integrate multiple features – chemical sensing, electrical sensing and stimulation, and physical manipulation – into a single device. However, manipulating biological samples on CMOS chips can be challenging. Traditional methods like optical and acoustic tweezers can generate heat, while dielectrophoresis – a technique that uses electric fields to manipulate particles – can be affected by the high ion concentrations in cell culture media. The ETH Zurich team’s shape-memory gripper technology overcomes these limitations by providing a low-power, reliable, and biocompatible solution for manipulating biological samples.
Looking ahead, the researchers envision future versions of the CMOS platform incorporating more electrodes for electrical sensing and stimulation of nerve cells, further expanding its capabilities for studying complex biological systems. The integration of advanced sensing technologies and precise manipulation tools promises to unlock new insights into human health and disease, paving the way for more effective diagnostics and therapies.
The next step for the team, as presented at the IEEE conference, is to refine the system for delicate handling of biological cells and organoids, and to accurately measure biochemicals like neurotransmitters. This continued development promises to further solidify the role of lab-on-a-chip technology in the future of biomedical research.
What are your thoughts on the potential of lab-on-a-chip technology? Share your comments below, and don’t forget to share this article with your network!